Journal article

C-reactive protein, immunothrombosis and venous thromboembolism

C Dix, J Zeller, H Stevens, SU Eisenhardt, KSCT Shing, TL Nero, CJ Morton, MW Parker, K Peter, JD McFadyen

Frontiers in Immunology | FRONTIERS MEDIA SA | Published : 2022

Abstract

C-reactive protein (CRP) is a member of the highly conserved pentraxin superfamily of proteins and is often used in clinical practice as a marker of infection and inflammation. There is now increasing evidence that CRP is not only a marker of inflammation, but also that destabilized isoforms of CRP possess pro-inflammatory and pro-thrombotic properties. CRP circulates as a functionally inert pentameric form (pCRP), which relaxes its conformation to pCRP* after binding to phosphocholine-enriched membranes and then dissociates to monomeric CRP (mCRP). with the latter two being destabilized isoforms possessing highly pro-inflammatory features. pCRP* and mCRP have significant biological effects ..

View full abstract

Grants

Funding Acknowledgements

HS is supported by a Monash University RTP Scholarship and Wheaton Family Scholarship. KP is supported by a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship. JM is supported by a NHMRC and Heart Foundation Early Career Fellowship. Funding from the Victorian Government Operational Infrastructure Support Scheme to St Vincent's Institute is acknowledged. MP is a National Health and Medical Research Council of Australia Leadership Fellow.